We report a very rare case of ovarian gastrinoma in the context of multiple endocrine neoplasia type I, including primary hyperparathyroidism and Zollinger-Ellison syndrome. Somatostatin receptor scintigraphy revealed the ovarian involvement at an early stage. Oophorectomy led to the final diagnosis and complete healing.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1067/mob.2001.108856 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Metastatic tumors to the urinary bladder: clinicopathologic study of 11 cases.
Int J Surg Pathol
August 2012
Department of Pathology, Mount Sinai School of Medicine, New York, NY 10029, USA.
Secondary neoplasms of the urinary bladder are uncommon, with metastatic tumors being an even rarer event. The authors studied the clinicopathology of 11 cases of metastatic tumors to bladder, which were collected from their archives between 1995 and 2010. The most common metastases in this series were breast.
View Article and Find Full Text PDFCalcium-sensing receptor in cancer: good cop or bad cop?
Endocrine
June 2009
Division of Endocrinology, Central Drug Research Institute, Chattar Manzil, Lucknow, India.
The extracellular calcium-sensing receptor (CaR) is a versatile 'sensor' for di- and polycationic molecules in the body. CaR plays a key role in the defense against hypercalcemia by "sensing" extracellular calcium levels in the parathyroid and kidney, the key organs maintaining systemic calcium homeostasis. Although mutation of CaR gene has so far not been associated with any malignancy, aberrant functions of CaR have implications in malignant progression.
View Article and Find Full Text PDFThe biology of cholecystokinin and gastrin peptides.
Curr Top Med Chem
September 2007
Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Cholecystokinin (CCK) and gastrin together constitute a family of homologous peptide hormones, which are both physiological ligands for the gastrin/CCK-B receptor, whereas the CCK-A receptor binds only sulfated CCK-peptides. CCK peptides are mainly produced in small intestinal endocrine I-cells and in cerebral neurons. CCK peptides regulate pancreatic enzyme secretion and growth, gallbladder contraction, intestinal motility, satiety and inhibit gastric acid secretion.
View Article and Find Full Text PDFA newly identified RET proto-oncogene polymorphism is found in a high number of endocrine tumor patients.
Hum Genet
July 2005
Department of Internal Medicine III, General Hospital Vienna, Vienna Medical University, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Multiple RET proto-oncogene transcripts, due to genomic variations and alternate splicing, have been described. To investigate endocrine tumor tissue characteristic RET proto-oncogene expression, we performed quantitative RT-PCR, Northern blot and Southern blot analyses of benign and malignant endocrine-derived tissues. We newly describe RET proto-oncogene expression in carcinoid-, gastrinoma- and insulinoma-derived tissue samples.
View Article and Find Full Text PDFOvarian gastrinoma in multiple endocrine neoplasia type I: a case report.
Am J Obstet Gynecol
January 2001
Department of Gynecology and Obstetrics, Hospital of Soissons, Reims, France.
We report a very rare case of ovarian gastrinoma in the context of multiple endocrine neoplasia type I, including primary hyperparathyroidism and Zollinger-Ellison syndrome. Somatostatin receptor scintigraphy revealed the ovarian involvement at an early stage. Oophorectomy led to the final diagnosis and complete healing.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!